AzTrials
AzTrials

Chronic PainNCT04171336

Animal-assisted Therapy for Children and Adolescents With Chronic Pain

A study testing Animal-assisted therapy in people with Chronic Pain, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chronic pain is highly prevalent in children and adolescents, up to one in four children will develop pain that persists or recurs for three or more months. Chronic pain is not only linked to significant psychological, physical, and social concerns for affected children and their families, but also places an enormous… Read more about this study

Who is it for?
Ages 8 to 16 years
Conditions the study is for
Chronic Pain
What is being tested?
Animal-assisted therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3 participants
Where
1 siteSwitzerland
Study dates
5 Sep 2020to 2 May 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children and adolescents aged 8-15 years
  • Suffering from chronic pain (i.e., persistent or recurrent pain for 3 or more months, associated with significant emotional distress or functional limitations)
  • Willing to work with therapy animals
  • Fluent in German
  • Willingness to participate

Who cannot join

  • children younger than 7 years or adolescents older than 16 years of age
  • Acute pain
  • Allergy to animals Aversion against animals

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Faculty of Psychology, University of Basel

    Basel, 40555

Other trials in Switzerland

About this study

Official title: Animal-assisted Group Therapy for Children and Adolescents Suffering From Chronic Primary Pain

Chronic pain is highly prevalent in children and adolescents, up to one in four children will develop pain that persists or recurs for three or more months. Chronic pain is not only linked to significant psychological, physical, and social concerns for affected children and their families, but also places an enormous burden on healthcare systems - in the United States, chronic pain costs around $19.5 billion dollars each year and ranks among the most expensive pediatric health problems. Chronic pain significantly decreases quality of life and is associated with numerous missing days at school or at work.

Several interventions exist, however, for some, the risk-benefit profile is not favorable, or the effect sizes are small and the clinical effect can be questioned. In general, a multidisciplinary approach that includes medical, psychological, and physiological aspects has been shown to be most promising in the treatment of chronic pain in children and adolescents.

Clinical impressions suggest that an Animal-assisted Therapy (AAT) intervention could be promising, but to the best of our knowledge, this is the first study to investigate the effectiveness of an AAT intervention for children and adolescents with chronic pain. With this pragmatic trials investigators aim to investigate the pre- and post-intervention differences in pain levels, levels of emotional distress, and quality of life within participants with chronic pain.

Conditions
Chronic Pain
Being tested
Animal-assisted therapy
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Animal-assisted therapyBehavioural

    Six sessions of animal-assisted intervention for children and adolescents, group format. The sessions will focus on psycho-education on pain, mindfulness, defocusing, getting active, and resources. Additionally, the intervention includes two family visits.

Study groups in NCT04171336
Study groupRoleWhat they receive
Animal-assisted group therapyExperimentalNot described
Receives: Behavioral: Animal-assisted therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Intensity assessed by Visual Analogue Scale

    Self-reported pain intensity scored on a 0-10 scale, reported before and after each session. Higher scores indicate higher pain intensity.

    Measured: 12 weeks

  2. Pain Severity assessed by Visual Analogue Scale

    Self-reported pain severity scored on a 0-10 scale, reported before and after each session. Higher scores indicate higher pain severity.

    Measured: 6 weeks

  3. Pain Interference assessed by Visual Analogue Scale

    Self-reported pain interference scored on a 0-10 scale, reported before and after each session. Higher scores indicate more pain interference.

    Measured: 6 weeks

  4. Pain Acceptance assessed by Visual Analogue Scale

    Self-reported pain acceptance scored on a 0-10 scale, reported before and after each session. Higher scores indicate more pain acceptance.

    Measured: 6 weeks

  5. Pain Defocussing assessed by Visual Analogue Scale

    Self-reported pain defocussing scored on a 0-10 scale, reported before and after each session. Higher scores indicate more pain defocussing.

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2019
  2. Study start5 Sep 2020
  3. Primary completion10 Apr 2021
  4. Study completion2 May 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Pragmatic trial
Masking
None (open label)
Enrolment
3 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04171336
Sponsor's protocol ID
AAT for CPP
Status last verified
May 2021
First submitted
14 Nov 2019
Last updated
18 May 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Locher C, Petignat M, Wagner C, Hediger K, Roth B, Gaab J, Koechlin H. Animal-Assisted Psychotherapy for Pediatric Chronic Pain: Case Series of an Open Pilot Study to Test Initial Feasibility and Potential Efficacy. J Pain Res. 2023 May 29;16:1799-1811. doi: 10.2147/JPR.S394270. eCollection 2023.

    PubMed 37273273

Questions about this trial

What is this clinical trial studying?

A study testing Animal-assisted therapy in people with Chronic Pain, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Intensity assessed by Visual Analogue Scale (time frame: 12 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04171336, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in